Molecules with extended half-lives, compositions and uses thereof
US7704497B2 · kind B2 · utility
70Cited by
28References
49Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 3, 2007 |
| Grant date | Apr 27, 2010 |
| Priority date | — |
| Expiry date | Sep 20, 2027 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/81
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides molecules, including IgGs, non-IgG immunoglobulins, proteins and non-protein agents, that have increased in vivo half-lives due to the presence of an IgG constant domain, or a portion thereof that binds the FcRn, having one or more amino acid modifications that increase the affinity of the constant domain or fragment for FcRn. Such proteins and molecules with increased half-lives have the advantage that smaller amounts and or less frequent dosing is required in the therapeutic, prophylactic or diagnostic use of such molecules.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.